towny, you need to read the "PUBLIC HEARING ON NEGOTIATING OBJECTIVES FOR A U.S.-U.K. TRADE AGREEMENT" (Jan 29,2019). Unfortunately it is almost 300 pages long but it lays out the stance of various departments within the American administration (and it is dull as dishwater to read) - but there are some very worrying 'demands' in there. That is a starter document and there are many other more focussed documents.towny44 wrote: 05 Jun 2019, 14:10I am hoping for a negotiated deal which should allow the status quo, or at least something very close, to continue for all our EU imports and for any ROW imports that we currently import under EU trade deals; and although I hope we will be able to negotiate our own new free trade deals, these would need to consider any impact they might have on existing trade.Kendhni wrote: 05 Jun 2019, 11:44What will happen is that NHS costs will rise, not drop. The US pharma companies will force the use of their drugs instead of cheaper generic drugs.towny44 wrote: 05 Jun 2019, 09:41What is the concern about the NHS and a US trade deal, is someone suggesting that we could be forced to privatise it as part of a trade deal? I doubt that very much, so what could they do, since most NHS trusts run a large deficit there would be little support for anyone taking over their running. I suppose drugs and medical supplies from the USA would become duty free putting UK suppliers under more competition, but that's what free trade deals do anyway. So just what is the concern?
Why would this happen Ken? As an ex buyer why would the NHS no longer be allowed to source their drugs from the most competitive source?
Similarly the insurance companies will squeeze the NHS on how much will be paid for treatment.
I thought the government (or we taxpayers) paid for all NHS services, why do you believe that a free trade deal would allow insurance companies to squeeze NHS costs?
Both of those are very bad news for the NHS and the British tax payer. If these companies get that foothold then it will only be a matter of a few years before we start seeing a two tier NHS between the haves and have nots (which sort of already exists) that will not be free at point-of-service.
Do not under-estimate the possible impact of this. There are a lot of senators in America with a vested interest in both Pharma and Medical insurance (not forgetting the farming, manufacturing and other industries) that have pretty much already spelled out exactly what they expect from an anglo-american trade deal.
If you have hard facts that support a different point of view I would really like to hear them.
One the big blockers for US pharma companies has been the sheer bulk buying power of the NHS and its willingness to utilise generic drugs. The pharmas companies are heavily invested into various senators in getting their way and they have made it clear that they want this on the agenda for any trade deal negotiations.
I am still trying to get my head around how the insurance companies will affect the market, but it appears that if they can get a foothold in the UK then they can set up their own private clinics pushing prices up and taking the 'cream' from the market. They could also limit payments for NHS services meaning the government/tax payer has to subsidise the NHS even more.
I know the NHS cannot continue indefinitely in its current form and it will have to probably move to a copay type of operation. The problem is do you really want the extortionate pricing that we see in the US coming over to the UK?
I have the same hopes for you of a good negotiated settlement, but having seen how well our negotiating team did in the 'easiest of negotiations' I am, not surprisingly, somewhat concerned about their abilities in the much more complex trade deal negotiations. The impact of an American trade agreement could seriously hamper our ability to trade with the EU due to possible enforced employment laws, health and safety, food standards and other elements that effectively come up for grabs (and it is easy to say that such things are up to us, but that only shows a lack of understanding of how trade agreements work).


